NeuMoDx Molecular, Inc.

ANN ARBOR, MI · Founded 2012 · CIK 0001546171 · Medtech · Acquired

Automated PCR molecular diagnostic platform for nucleic acid testing

neumodx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$55M
5 Form D · May 2018
101 months since last filing
Contracts
—
No federal contracts on record
Patents
40
25 granted · 15 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$200,000
Private capital raisedForm D · SEC$10,546,943
Private capital raisedForm D · SEC$19,999,995
Private capital raisedForm D · SEC$4,000,000
Private capital raisedForm D · SEC$20,039,942
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
812Fresenius Medical Care South Grove City, LLC—$2.3M
813MSTM, LLC——
814Siesta Medical, Inc.—$1.9M
815NeuMoDx Molecular, Inc.—$55M
816Soliton, Inc.—$15M
817Nano Precision Medical, Inc.—$6.6M
818Innoblative Designs—$4.4M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Sundaresh BrahmasandraExecutive Officer
  • William BurkothDirector
  • Jan GarfinkleDirector
  • Edward MichaelDirector
  • Nicole WalkerDirector
  • Jeffrey WilliamsDirector · Executive Officer

Patents

USPTO · 25 granted of 40

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.